A new modeling study led by researchers at Washington University School of Medicine in St. Louis (WashU Medicine) warns that if fewer U.S. infants receive the rotavirus vaccine, thousands more young children could be hospitalized or require emergency care each year due to severe diarrhea and vomiting. The study, published Oct. 26 in JAMA Network Open, comes amid a shift in federal guidance that has already sparked legal challenges.

Rotavirus is a leading cause of severe diarrheal illness in young children, causing gastroenteritis — inflammation of the stomach and intestines — with symptoms including vomiting, fever, watery diarrhea and abdominal pain. The vaccine, typically given to infants between 2 and 6 months of age, has been a routine part of childhood immunization schedules for years.

In January, the Centers for Disease Control and Prevention (CDC) dropped its long-standing recommendation for routine rotavirus vaccination of all infants, replacing it with a policy of "shared clinical decision-making" between clinicians and families. According to WashU Medicine, a federal judge temporarily blocked that change in March, but the uncertainty around vaccination rates has prompted researchers to model potential consequences.

Anne Mobley Butler, an associate professor in WashU Medicine's Division of Infectious Diseases, led the study alongside collaborators at Duke University. The team modeled what would happen if 10%, 20% or 30% of U.S. infants who would otherwise be fully vaccinated against rotavirus — based on current vaccination rates — did not receive the vaccine. The results showed that even a 10% drop in vaccination could lead to thousands of additional hospitalizations and emergency department visits among children under 2.

The study did not specify exact numbers of projected additional cases, but the researchers emphasized that even modest declines in vaccination coverage could significantly strain pediatric healthcare resources. The findings highlight the potential public health impact of policy changes that reduce routine immunization uptake.

For university students studying public health, medicine, or health policy, the study offers a concrete example of how shifts in clinical guidelines — even those subject to legal review — can have measurable downstream effects on population health. Students in pre-med or nursing programs may also find the research relevant to understanding vaccine-preventable diseases and the importance of maintaining high immunization rates.

The study was published in JAMA Network Open and is available on the journal's website. The research was supported by the National Institutes of Health and the Agency for Healthcare Research and Quality, according to WashU Medicine.